Evidence map›Paper›PMID 41111868›Full record

ReviewCureus2025

Impact of Rehabilitation Therapy on Disease Activity, Function, and Quality of Life in Rheumatoid Arthritis: A Systematic Review.

Nimota Alapa, Barbara Tafuto, Rahul Mittal

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nimota AlapaHealth Informatics, Rutgers University, Piscataway, USA.
Barbara TafutoHealth Informatics, Rutgers University, Piscataway, USA.
Rahul MittalHealth Informatics, Rutgers University, Piscataway, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that leads to persistent joint inflammation and progressive disability. While treatment with disease-modifying anti-rheumatic drugs (DMARDs) remains the primary approach, rehabilitation therapies such as exercise and physical therapy provide long-term outcomes. This systematic review evaluates the impact of rehabilitation interventions on RA patients receiving DMARD therapy compared with standard care without therapy. Systematic literature research was conducted between January 2013 and July 2025 on PubMed, Cochrane Library, and Embase with predefined PRISMA guidelines. Randomized controlled trials, systematic reviews, and respective cohorts were included if they examined rehabilitation interventions, such as exercise or physical therapy, in addition to DMARDs, with outcomes related to disease activity, physical function, or quality of life. Risk of bias was assessed using Cochrane RoB 1.0 tools. Eight randomized controlled trials involving 930 participants met the inclusion criteria. Most participants were women in their mid-50s to early 60s, with disease duration ranging from four to 16 years. Across studies, rehabilitation interventions were associated with meaningful improvements in physical function, reflected by reductions of 0.3 to 0.6 points in Health Assessment Questionnaire scores. Several studies also reported decreases of 0.4 to 0.7 points in Disease Activity Score (DAS28-ESR [erythrocyte sedimentation rate]/CRP [C-reactive protein]), particularly with multidisciplinary programs and structured exercise regimens. Quality-of-life measures similarly demonstrated improvement. Rehabilitation to standard pharmacologic therapy may provide clinically significant benefits in disease control, functional capacity, and overall well-being. However, limitations included variability in reported outcomes and modest sample sizes, which restrict the generalizability of results. Overall, the evidence supports the incorporation of rehabilitation, particularly exercise and physical therapy, into standard care for RA patients as an effective complement to pharmacological management.

Indexed as

disease activitydmardsphysical functionquality of liferehabilitationrheumatoid arthritis

Identifiers

PMID41111868
PMCPMC12535218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.